Keio University

Completion of Follow-Up Observations in Clinical Study on Regenerative Medicine Using iPS Cell-Derived Neural Stem/Progenitor Cells to Treat Subacute Spinal Cord Injuries

Publish: April 02, 2025
Public Relations Office

April 2, 2025

Keio University School of Medicine

Keio University Hospital

National Hospital Organization Osaka National Hospital

National Hospital Organization Murayama Medical Center

Keio University Hospital has completed the scheduled follow-up observations and data collection for all four cases in its clinical study on regenerative medicine using iPS cell-derived neural stem/progenitor cells to treat subacute spinal cord injuries.

Moving forward, we will promptly submit a comprehensive report and summary to the Minister of Health, Labour and Welfare in accordance with the Act on Securing Safety of Regenerative Medicine and related regulations.